- Home
- LXEO vs DTF Comparison
LXEO vs DTF Comparison
Compare LXEO & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- DTF
- Stock Information
- Founded
- LXEO 2017
- DTF 1991
- Country
- LXEO United States
- DTF United States
- Employees
- LXEO N/A
- DTF N/A
- Industry
- LXEO
- DTF Investment Managers
- Sector
- LXEO
- DTF Finance
- Exchange
- LXEO Nasdaq
- DTF Nasdaq
- Market Cap
- LXEO 93.9M
- DTF 78.2M
- IPO Year
- LXEO 2023
- DTF N/A
- Fundamental
- Price
- LXEO $3.91
- DTF $11.17
- Analyst Decision
- LXEO Strong Buy
- DTF
- Analyst Count
- LXEO 5
- DTF 0
- Target Price
- LXEO $16.60
- DTF N/A
- AVG Volume (30 Days)
- LXEO 697.6K
- DTF 21.1K
- Earning Date
- LXEO 08-11-2025
- DTF 01-01-0001
- Dividend Yield
- LXEO N/A
- DTF 3.64%
- EPS Growth
- LXEO N/A
- DTF N/A
- EPS
- LXEO N/A
- DTF 0.44
- Revenue
- LXEO N/A
- DTF N/A
- Revenue This Year
- LXEO N/A
- DTF N/A
- Revenue Next Year
- LXEO N/A
- DTF N/A
- P/E Ratio
- LXEO N/A
- DTF $24.34
- Revenue Growth
- LXEO N/A
- DTF N/A
- 52 Week Low
- LXEO $1.45
- DTF $10.29
- 52 Week High
- LXEO $19.50
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- LXEO 55.22
- DTF 41.95
- Support Level
- LXEO $3.62
- DTF $11.16
- Resistance Level
- LXEO $4.29
- DTF $11.22
- Average True Range (ATR)
- LXEO 0.45
- DTF 0.03
- MACD
- LXEO 0.04
- DTF -0.00
- Stochastic Oscillator
- LXEO 58.68
- DTF 0.00
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.